Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53

Journal of Virology

Volumn 80, Issue 24, 2006, Pages 12408-12413

  O'Nions, Jenny ^a   Turner, Abigail ^a   Craig, Richard ^a   Allday, Martin J ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Faculty of Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DOUBLE STRANDED DNA; MITOGENIC AGENT; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DNA STRAND BREAKAGE; EPSTEIN BARR VIRUS; EXPOSURE; GENOTOXICITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; VIRUS LATENCY;

B-LYMPHOCYTES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; MUTAGENS; PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN HERPESVIRUS 4;

EID: 33845467396     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01363-06     Document Type: Article

References (17)

1. Allday, M. J., G. J. Inman, D. H. Crawford, and P. J. Farrell. 1995. DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J. 14:4994-5005.
2. Allday, M. J., A. Sinclair, G. Parker, D. H. Crawford, and P. J. Farrell. 1995. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14:1382-1391.
3. Bornkamm, G. W., and W. Hammerschmidt. 2001. Molecular virology of Epstein-Barr virus. Philos. Trans. R. Soc. London B 356:437-459.
4. Cannell, E. J., P. J. Farrell, and A. J. Sinclair. 1998. Cell cycle arrest following exposure of EBV-immortalised B-cells to gamma irradiation correlates with inhibition of cdk2 activity. FEBS Lett. 439:297-301.
5. Eastman, A. 1987. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther. 34:155-166.
6. Frank, A. J., S. J. Proctor, and M. J. Tilby. 1996. Detection and quantification of melphalan-DNA adducts at the single cell level in hematopoietic tumor cells. Blood 88:977-984.
7. Krauer, K. G., A. Burgess, M. Buck, J. Flanagan, T. B. Sculley, and B. Gabrielli. 2004. The EBNA-3 gene family proteins disrupt the G2/M checkpoint. Oncogene 23:1342-1353.
8. Meek, D. W. 2004. The p53 response to DNA damage. DNA Repair (Amsterdam) 3:1049-1056.
9. Oda, K., H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura, and Y. Taya. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser46-phosphorylated p53. Cell 102:849-862.
10. Olive, P. L., and J. P. Banath. 1993. Detection of DNA double-strand breaks through the cell cycle after exposure to X-rays, bleomycin, etoposide and 125IdUrd. Int. J. Radiat. Biol. 64:349-358.
11. O'Nions, J., and M. J. Allday. 2004. Deregulation of the cell cycle by the Epstein-Barr virus. Adv. Cancer Res. 92:119-186.
12. O'Nions, J., and M. J. Allday. 2003. Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2. Oncogene 22:7181-7191.
13. O'Nions, J., and M. J. Allday. 2004. Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens. J. Gen. Virol. 85:881-895.
14. Saridakis, V., Y. Sheng, F. Sarkari, M. N. Holowaty, K. Shire, T. Nguyen, R. G. Zhang, J. Liao, W. Lee, A. M. Edwards, C. H. Arrow-smith, and L. Frappier. 2005. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell 18:25-36.
15. Schlade-Bartusiak, K., A. Stembalska-Kozlowska, M. Bernady, M. Kudyba, and M. Sasiadek. 2002. Analysis of adaptive response to bleomycin and mitomycin C. Mutat. Res. 513:75-81.
16. Shieh, S. Y., J. Ahn, K. Tamai, Y. Taya, and C. Prives. 2000. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:289-300.
17. 2/M checkpoint activated by genotoxins. Mol. Cell. Biol. 20:1344-1360.